Service
@{item.Title}
News
SCCS Issued Scientific Advice on the safety of Diethylamino Hydroxybenzoyl Hexyl Benzoate (DHHB)
On June 30, 2025, the Scientific Committee on Consumer Safety (SCCS) of the European Union issued scientific opinion(SCCS/1678/25) on Diethylamino Hydroxybenzoyl Hexyl Benzoate (DHHB) (CAS/EC No. 302776-68-7/443-860-6). Previously, on February 17, 2025, the SCCS published the scientific opinion on this substance which was open for comments. The scientific advice released this time is consistent with the assessment conclusions proposed during the comment phase and further confirms the maximum safe level and recommends the target maximal level of DnHexP as an impurity in DHHB.
07-23
Vietnam Proposes Amendments to the Cosmetic Management Regulations
On July 3, 2025, the Vietnam Ministry of Health issued Circular No. 34/2025/TT-BYT, proposing amendments to the cosmetic management regulations. The public consultation period is open until August 18, 2025.
07-23
SCCS Issued Scientific Opinion on Tea Tree Oil
On 6 June, 2025, the Scientific Committee on Consumer Safety (SCCS) of the European Union issued scientific opinion(SCCS/1681/25) on Tea Tree Oil (CAS/EC No. 68647-73-4 /285-377-1). The deadline for comments is set for 18 August 2025.
07-17
SCCS Issued Opinion on Ethylhexyl Methoxycinnamate (EHMC)
On 30 June, 2025, the Scientific Committee on Consumer Safety (SCCS) of the European Union issued scientific opinion(SCCS/1671/24) on Ethylhexyl Methoxycinnamate (EHMC) (CAS No. 5466-77-3/83834-59-7, EC No. 226-775-7/629-661-9).
07-15
Why choose CIRS Biotech?
Global Resources
With HQs in China, CIRS Group has branch companies in USA, UK, France, Korea, Japan, Ireland, that can provide cutting edge technical information and support to our clients
Rich Experience
CIRS Group has 17 years accumulation on testing and compliance service technical abilities. CIRS Group has served more than 20,000 clients, including 60+ world top 500 companies
One-Stop-Service Capability
Service range includes cosmetic ingredient development, physical/chemical tests, in-vivo toxicological tests, toxicology risk assessment, in-vitro toxicological study, clinical efficacy study, in-vitro efficacy study, raw material registration, product registration and etc.
Experts Team
Technical team built with experts from personal care industry, College Professor, Risk Assessment Expert, Toxicological Expert, Regulatory Compliance Expert
Professional Equipment and Technique
Capability includes the professional instruments and techniques for in-vitro efficacy study, in-vitro safety study, clinical efficacy study, in-vitro study method development, ingredient development and improvement
Why choose CIRS Biotech?
01
Global Resources
With HQs in China, CIRS Group has branch companies in USA, UK, France, Korea, Japan, Ireland, that can provide cutting edge technical information and support to our clients
02
Rich Experience
CIRS Group has 17 years accumulation on testing and compliance service technical abilities. CIRS Group has served more than 20,000 clients, including 60+ world top 500 companies
03
Experts Team
Technical team built with experts from personal care industry, College Professor, Risk Assessment Expert, Toxicological Expert, Regulatory Compliance Expert
04
One-Stop-Service Capability
Service range includes cosmetic ingredient development, physical/chemical tests, in-vivo toxicological tests, toxicology risk assessment, in-vitro toxicological study, clinical efficacy study, in-vitro efficacy study, raw material registration, product registration and etc.
05
Professional Equipment and Technique
Capability includes the professional instruments and techniques for in-vitro efficacy study, in-vitro safety study, clinical efficacy study, in-vitro study method development, ingredient development and improvement